Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Alnylam Pharmace. buy melinda

Start price
€109.44
27.11.19 / 50%
Target price
-
04.11.21
Performance (%)
65.25%
End price
€180.85
16.10.21
Summary
This prediction ended on 16.10.21 with a price of €180.85. With a performance of 65.25% the BUY prediction by melinda was a big success. melinda has 50% into this prediction

Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.

Performance without dividends (%)
Name 1w 1m 1y 3y
Alnylam Pharmace. 2.519% 2.519% -20.377% 19.765%
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

According to melinda what are the pros and cons of Alnylam Pharmace. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Alnylam Pharmace. diskutieren
Prediction Buy
Perf. (%) 65.25%
Target price 150.000
Change
Ends at 04.11.21

Kursziel gesetzt auf 150,0

Prediction Buy
Perf. (%) 65.25%
Target price
Change
Ends at 04.11.21

Kursziel geändert auf 0,0

In the thread Alnylam Pharmace. diskutieren

Buy Alnylam Pharmace.

In the thread Trading Alnylam Pharmace.
Prediction Buy
Perf. (%) 65.25%
Target price
Change
Ends at 04.11.21

Buy beendet

Stopped prediction by melinda for Alnylam Pharmace.

Alnylam Pharmace.

Start price
Target price
Perf. (%)
€180.85
16.10.21
€160.00
16.10.22
-6.22%
24.10.21

Could be worthwhile Investment >10% per year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€81.26
28.09.18
€95.61
22.01.19
-10.01%
22.01.19

Could be worthwhile Investment >10% per year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€128.12
12.03.18
€144.32
13.09.18
-33.29%
13.09.18

Could be worthwhile Investment >10% per year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€113.81
16.11.17
€126.28
12.03.18
11.75%
12.03.18

Could be worthwhile Investment >10% per year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€102.68
20.09.17
€125.38
10.11.17
22.22%
10.11.17

Could be worthwhile Investment >10% per year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€113.84
20.09.17
€139.00
10.11.17
22.22%
10.11.17

Could be worthwhile Investment >10% per year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€67.65
09.09.17
€76.67
20.09.17
30.03%
20.09.17

Could be worthwhile Investment >10% per year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€75.00
09.09.17
€85.00
20.09.17
30.03%
20.09.17

Could be worthwhile Investment >10% per year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€47.11
24.09.13
€52.00
24.03.14
8.26%
24.03.14

Could be worthwhile Investment >10% per year